These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 9212064)
1. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription. Han Y; Watling D; Rogers NC; Stark GR Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064 [TBL] [Abstract][Full Text] [Related]
2. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation. Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911 [TBL] [Abstract][Full Text] [Related]
3. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
4. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element. Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725 [TBL] [Abstract][Full Text] [Related]
5. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. Jabbour HN; Critchley HO; Boddy SC J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641 [TBL] [Abstract][Full Text] [Related]
6. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683 [TBL] [Abstract][Full Text] [Related]
7. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991 [TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538 [TBL] [Abstract][Full Text] [Related]
9. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625 [TBL] [Abstract][Full Text] [Related]
10. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5. Pezet A; Ferrag F; Kelly PA; Edery M J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112 [TBL] [Abstract][Full Text] [Related]
11. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. Dogusan Z; Hooghe R; Verdood P; Hooghe-Peters EL J Neuroimmunol; 2001 Nov; 120(1-2):58-66. PubMed ID: 11694320 [TBL] [Abstract][Full Text] [Related]
12. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter. Selvaraj NG; Omi E; Gibori G; Rao MC Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534 [TBL] [Abstract][Full Text] [Related]
13. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin. Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136 [TBL] [Abstract][Full Text] [Related]
15. In vitro expression of long and short ovine prolactin receptors: activation of Jak2/STAT5 pathway is not sufficient to account for prolactin signal transduction to the ovine beta-lactoglobulin gene promoter. Bignon C; Daniel N; Belair L; Djiane J J Mol Endocrinol; 1999 Oct; 23(2):125-36. PubMed ID: 10514551 [TBL] [Abstract][Full Text] [Related]
16. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N; Frank DA; Griffin JD J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285 [TBL] [Abstract][Full Text] [Related]
17. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159 [TBL] [Abstract][Full Text] [Related]
18. Participation of JAK and STAT proteins in growth hormone-induced signaling. Han Y; Leaman DW; Watling D; Rogers NC; Groner B; Kerr IM; Wood WI; Stark GR J Biol Chem; 1996 Mar; 271(10):5947-52. PubMed ID: 8621469 [TBL] [Abstract][Full Text] [Related]
19. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]